AFT Pharma resets on US after setback

Jul 27, 2022 | Companies, Latest News

27.7.22 AFT Pharmaceuticals’ Pascomer clinical study in the US has been completed and not with the outcome hoped. The medicine did not reach the threshold on the IGA scale that the US Food and Drug Administration (FDA) considered necessary for its registration in the US as topical treatment for facial angiofibromas AFT also announced its […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options